Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of low-dose AS03-adjuvanted influenza vaccine versus Fluarix in healthy adults
2007-003776-18Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of low-dose influenza vaccine, AS03 and Fluarix in influenza (5 arms), sponsored by GSK. Primary endpoints: Immunological non-inferiority by GMT and HI antibody response. Started Jul 2007; status: completed.
02
Drugs
low-dose influenza vaccineAS03Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-003776-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003776-18.